Browse > Article

An Optimal Process Design U sing a Robust Desirability Function(RDF) Model to Improve a Process/Product Quality on a Pharmaceutical Manufacturing Process  

Park, Kyung-Jin (Department of Systems Management and Engineering, Inje University)
Shin, Sang-Mun (Department of Systems Management and Engineering, Inje University)
Jeong, Hea-Jin (Department of Industrial Management System Engineering, Dong-A university)
Publication Information
Journal of Korean Society of Industrial and Systems Engineering / v.33, no.1, 2010 , pp. 1-9 More about this Journal
Abstract
Quality design methodologies have received constituent attention from a number of researchers and practitioners for more than twenty years. Specially, the quality design for drug products must be carefully considered because of the hazards involved in the pharmaceutical industry. Conventional pharmaceutical formulation design problems with mixture experiments have been typically studied under the assumption of an unconstrained experimental region with a single quality characteristic. However, real-world pharmaceutical industrial situations have many physical limitations. We are often faced with multiple quality characteristics with constrained experimental regions. ln order to address these issues, the main objective of this paper is to propose a robust desirability function (RDF) model using a desirability function (DF) and mean square error (MSE) to simultaneously consider a number of multiple quality characteristics. This paper then present L-pseudocomponents and U-pseudocomponents to handle physical constraints. Finally, a numerical example shows that the proposed RDF can efficiently be applied to a pharmaceutical process design.
Keywords
Robust Design; Mixture Experiment; Simplex Design; Desirability Function;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Shin, S., Park, K., Choi, Y., Lee, S., Choi, G. J., Kwon, B., and Cho, B. R.; "Development of Process Analytical Technology (PAT) for Total Quality Innovation on Pharmaceutical Processes," Journal of Korean Pharmaceutical Sciences, 37(6) : 329-338, 2007.   과학기술학회마을
2 Tong, L. I., Wang, C. H., and Chen, H. C.; "Optimization of multiple responses using prineipal component analysis and technique for order preference by similarity to ideal solution," The International Journal of Advanced Manufacturing Technology, 27: 407-414, 2005.   DOI
3 U. S. Food and Drug Administration(2004), Innovation and Continuous Improvement in Pharmaceutical Manufacturing Pharmaceutical CGMPs for the 21st Century, http://ww w.fda.gov/cder/gmp/gmp2004/manufSciWP.pdf.
4 Yang, Y. Q., Wang, S. Q., Dulaimi, M., and Low, S. P.; "A fuzzy quality function deployment system for buildable design decision-makings," Automation in Construction, 12 : 381-393, 2003.   DOI   ScienceOn
5 Choi, M. and Shin, S.; "Optimizing Quality Levels and Development Costs for Developing an Integrated Information Seeurity System," Lecture Notes in Computer Science, 4867 : 359-370, 2008.
6 Gao, P., Witt, M. J., Haskell, R. J., Zamora, K. M., and Shifflett, J. R.; "Application of a Mixture Experimental Design in the Optimization of a Self-Emulsifying Formulation with a High Drug Load," Pharmaceutical Development and Technology, 9(3) : 301-309, 2004.
7 Lin, D. K. J. and Tu, W.; "Dual response surface optimization," Journal of Quality Technology, 27 : 34-39, 1995.
8 Liao, H. C.; "Multi-response optimization using weighted principal component," The International Journal of Advanced Manufacturing Technology, 27 : 720-725, 2006.   DOI
9 Myers, R. H. and Montgomery, D. C.; Response Surface Methodology, John Wiley and Sons, New York, 1955.
10 Montgomery, D. C.; "Design and Analysis of Experiments," 5th Edition, John Wiley and Sons, New York, 2001.
11 Reddy, P. B. S., Nishina, K., and Subash Babu, A.; "Unification of robust design and goal programming for multiresponse optimization-a case study," Quality and Reliability Engineering International, 13 : 371-383, 1997.   DOI   ScienceOn
12 Scheffe, H.; "Experiments with Mixtures," Journal of the Royal Statistical Society. Series B, 20(2) : 344-360, 1958.
13 Scheffe, H.; "The Simplex-Centroid Design for Experiments with Mixture," Journal of the Royal Statistical Society, Series B, 25(2) : 235-263, 1963.
14 Snee, R. D. and Marquardt, D. W.; "Extreme Vertices Designs for Linear Mixture Models," Technometrics, 16(3) : 399-408, 1974.   DOI   ScienceOn
15 Anderson-Cook, C. M., Goldfarb, H. B., Borror, C. M., Montgomery, D. C., Canter, K. G., and Twist, J.N.; "Mixture and Mixture-Process Variable Experiments for Pharmaceutical Applications," Pharmaceutical Statistics, 3(4) : 247-260, 2004.   DOI   ScienceOn
16 Su, C. T. and Tong, L. I.; "Multi-response robust design by principal component analysis, Total Quality Management and Business Excellence," 8 : 409-416, 1997.   DOI   ScienceOn
17 Shin, S., Cho, B. R., Zelaya, M. I., and Choi, Y.; "Experimental Design Aspects for Nanoparticle Pharmaceutical Formulations," Institute of Industrial Engineering Research Conference proceedings, Nashville, TN, 2007.
18 식품의약품안정청; 대통령업무보고-2007년도 주요업무계획, 2007
19 Bruttin, F. and Dean, D.; "Best Practice Performance in Pharmaceutical Production," Pharmaceutical Manufacturing International, Boardroom Issues, 13-16, 1997.
20 Benson, R. S. and MacCabe, D. J.; "From good manufacturing practice to good manufacturing performance," Pharmaceutical Engineeing, 24(4) : 26-34, 2004.
21 Campisi, B., Chicco, D., Vojnovic, D., and Phan-Tan-Luu, R.; "Experimental Design for a Pharmaceutical Formulation : Optimisation and Robustness," Journal of Pharmaceutical and Biomedical Analysis, 18(1-2) : 57-65, 1998.   DOI
22 Cornell, J. A.; "Experiments with Mixtures: Designs, Models, and The Analysis of Mixture Data," John Wiley and Sons, New York, 1981.
23 Cho, B. R.; "Optimization issues in quality engineering," Ph. D. Dissertation, School of Industrial Engineering, University of Oklahoma, 1994.